Markets › United States › NYSE › DVA

DaVita Inc

NYSE:DVAHealthcareCBOE:SPESGNASDAQ:NQUSMG

$187.00−0.17%At closeAt close · Tue 20 Oct · ≈ AED 686.76 · Market cap $11.93B · Next earnings Fri 23 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	30.8%	31.4%	29.3%	31.5%	32.9%	27.0%	—	—
Operating margin	14.7%	15.5%	11.5%	13.2%	16.3%	14.7%	14.7%	+0.0 pts
Net margin	6.7%	8.4%	4.8%	5.7%	7.3%	5.5%	7.9%	+2.4 pts
EBITDA margin	19.5%	21.4%	17.7%	19.1%	21.3%	19.4%	—	—
Return on equity	55.9%	129.5%	78.7%	65.5%	773.1%	−114.7%	93.1%	+207.8 pts
Return on assets	4.6%	5.7%	3.3%	4.1%	5.4%	4.3%	6.2%	+1.9 pts
Return on capital employed	11.7%	12.2%	9.4%	11.2%	14.6%	14.0%	—	—
Debt / equity	8.1×	15.9×	16.6×	10.5×	99.6×	−23.1×	13.0×	+156.2%
Debt / assets	65.9%	69.9%	69.8%	65.8%	69.8%	86.1%	—	—
Interest coverage	5.6×	6.3×	3.8×	4.0×	4.4×	3.7×	—	—
Current ratio	1.3×	1.3×	1.2×	1.2×	1.3×	1.3×	1.3×	+0.0%
Quick ratio	1.2×	1.3×	1.2×	1.1×	1.2×	1.2×	—	—
Cash ratio	0.1×	0.2×	0.1×	0.1×	0.3×	0.2×	0.2×	+0.0%
Asset turnover	0.7×	0.7×	0.7×	0.7×	0.7×	0.8×	—	—
Inventory turnover	71.6×	74.2×	75.2×	58.1×	63.9×	62.0×	—	—
Receivables turnover	4.7×	4.8×	4.6×	5.0×	5.0×	4.6×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—